Bangi Inc (BNGI)

[~BC~]

Founder and Chairman of the Board of Directors, Dr. Joseph Sinkule is a serial entrepreneur and a 28-year biotech veteran with extensive biotech startup experience. Joe has taken several drug and recombinant protein products from discovery thru FDA approval and licensure. He was previously Sr. VP of R&D at a NASDAQ-listed biotech company and Director of Clinical Research at Immunex. Joe founded five other biotech companies and two CROs, and currently serves on the Boards of four healthcare companies.


Immunex - Merged with Amgen:

http://www.seattlepi.com/business/51075_immunex18.shtml

Amgen Inc. has agreed to buy Seattle's largest biotech, Immunex Corp., for $16 billion in stock and cash, the companies said yesterday, after days of speculation about a possible deal.


Dr. Sinkule is also on the board of directors for Apthera:

http://www.apthera.com/board_bio.php?id=5


More on Dr. Sinkule:

http://www.medelis.com/joseph_sinkule.html

http://www.genbiopro.com/about.php?id=4

http://virionics.com/about.php?id=2

http://www.linkedin.com/pub/joseph-sinkule/4/33/912

Joseph Sinkule’s Experience

*
Founder and Chairman of the Board
GenBioPro, Inc

(Biotechnology industry)

2005 — Present (6 years )

Super-Generics and Super-Biosimilar Drugs for Oncology and Oncology Supportive Care global markets.
*
Founder and Chairman of the Board
C-Pharma, Inc.

(Biotechnology industry)

2003 — Present (8 years )

C-Pharma is focused on developing preventative vaccines and better anti-viral therapies to prevent and treat hepatitis C viral infections around the world.